{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:05:09Z","timestamp":1780358709001,"version":"3.54.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/07607-8"],"award-info":[{"award-number":["2013\/07607-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/03196-0"],"award-info":[{"award-number":["2019\/03196-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/19488-0"],"award-info":[{"award-number":["2019\/19488-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2020\/13940-5"],"award-info":[{"award-number":["2020\/13940-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.lfs.2023.121906","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:34:06Z","timestamp":1688171646000},"page":"121906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Agomelatine inhibits platelet aggregation through melatonin receptor-dependent and independent mechanisms"],"prefix":"10.1016","volume":"328","author":[{"given":"Julia Modesto","family":"Vicente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Honaiser","family":"Lescano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Bordin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola Zakia","family":"M\u00f3nica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Forato","family":"Anh\u00ea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lfs.2023.121906_bb0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001648-199307000-00003","article-title":"Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults","volume":"4","author":"Anda","year":"1993","journal-title":"Epidemiology"},{"issue":"2","key":"10.1016\/j.lfs.2023.121906_bb0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00006842-199603000-00003","article-title":"Hopelessness and risk of mortality and incidence of myocardial infarction and cancer","volume":"58","author":"Everson","year":"1996","journal-title":"Psychosom. Med."},{"issue":"12","key":"10.1016\/j.lfs.2023.121906_bb0015","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1161\/01.CIR.94.12.3123","article-title":"Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up","volume":"94","author":"Pratt","year":"1996","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lfs.2023.121906_bb0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0163-8343(95)00100-X","article-title":"Depression in patients with coronary heart disease. A 12-month follow-up","volume":"18","author":"Hance","year":"1996","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"8","key":"10.1016\/j.lfs.2023.121906_bb0025","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1001\/archinte.1989.00390080059014","article-title":"The nature and course of depression following myocardial infarction","volume":"149","author":"Schleifer","year":"1989","journal-title":"Arch. Intern. Med."},{"issue":"10","key":"10.1016\/j.lfs.2023.121906_bb0030","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1176\/ajp.153.10.1313","article-title":"Exaggerated platelet reactivity in major depression","volume":"153","author":"Musselman","year":"1996","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl. 4","key":"10.1016\/j.lfs.2023.121906_bb0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1067\/mhj.2000.109978","article-title":"Are platelets the link between depression and ischemic heart disease?","volume":"140","author":"Nemeroff","year":"2000","journal-title":"Am. Heart J."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2023.121906_bb0040","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/01.psy.0000164227.63647.d9","article-title":"Depression, alterations in platelet function, and ischemic heart disease","volume":"67","author":"Bruce","year":"2005","journal-title":"Psychosom. Med."},{"issue":"7","key":"10.1016\/j.lfs.2023.121906_bb0045","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1084\/jem.20012044","article-title":"A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation","volume":"196","author":"Massberg","year":"2002","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.lfs.2023.121906_bb0050","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00392-004-0146-5","article-title":"P-selectin in arterial thrombosis","volume":"93","author":"Merten","year":"2004","journal-title":"Z. Kardiol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121906_bb0055","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCRESAHA.112.300570","article-title":"Integrin \u03b1IIb\u03b23: from discovery to efficacious therapeutic target","volume":"112","author":"Bledzka","year":"2013","journal-title":"Circ. Res."},{"issue":"18","key":"10.1016\/j.lfs.2023.121906_bb0060","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1161\/01.CIR.0000017140.26466.F5","article-title":"Platelet-monocyte aggregates: bridging thrombosis and inflammation","volume":"105","author":"Freedman","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lfs.2023.121906_bb0065","first-page":"248","article-title":"Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis","volume":"102","author":"Jennings","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.lfs.2023.121906_bb0070","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.thromres.2007.10.005","article-title":"Platelet collagen receptors, signaling and antagonism: emerging approaches for the prevention of intravascular thrombosis","volume":"122","author":"Surin","year":"2008","journal-title":"Thromb. Res."},{"issue":"9","key":"10.1016\/j.lfs.2023.121906_bb0075","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0006-2952(01)00760-2","article-title":"Taming platelets with cyclic nucleotides","volume":"62","author":"Schwarz","year":"2001","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121906_bb0080","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0006-2952(00)00417-2","article-title":"The integrin \u03b1IIb\/\u03b23 in human platelet signal transduction","volume":"60","author":"Payrastre","year":"2000","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121906_bb0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.thromres.2011.04.018","article-title":"P-selectin ligation induces platelet activation and enhances microaggregate and thrombus formation","volume":"128","author":"Th\u00e9or\u00eat","year":"2011","journal-title":"Thromb. Res."},{"issue":"10","key":"10.1016\/j.lfs.2023.121906_bb0090","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1111\/bcp.14299","article-title":"Differential effects of antidepressant subgroups on risk of acute myocardial infarction: a nested case-control study","volume":"86","author":"Alqdwah-Fattouh","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121906_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087026","article-title":"The antidepressant 5-HT2A receptor antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced platelet function","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.lfs.2023.121906_bb0100","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrd3140","article-title":"Agomelatine, the first melatonergic antidepressant: discovery, characterization and development","volume":"9","author":"de Bodinat","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.lfs.2023.121906_bb0105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1600-079X.1993.tb00501.x","article-title":"Inhibitory effect of melatonin on platelet activation induced by collagen and arachidonic acid","volume":"14","author":"Kornblihtt","year":"1993","journal-title":"J. Pineal Res."},{"issue":"3\u20134","key":"10.1016\/j.lfs.2023.121906_bb0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1600-079X.1991.tb00468.x","article-title":"Inhibition of human platelet aggregation and thromboxane B2 production by melatonin. Correlation with plasma melatonin levels","volume":"11","author":"Vacas","year":"1991","journal-title":"J. Pineal Res."},{"issue":"3\u20134","key":"10.1016\/j.lfs.2023.121906_bb0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-079X.1991.tb00465.x","article-title":"Melatonin effect on arachidonic acid metabolism to cyclooxygenase derivatives in human platelets","volume":"11","author":"Martinuzzo","year":"1991","journal-title":"J. Pineal Res."},{"issue":"1","key":"10.1016\/j.lfs.2023.121906_bb0120","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1210\/jcem-70-1-246","article-title":"Inhibition of human platelet aggregation and thromboxane-B2 production by melatonin: evidence for a diurnal variation","volume":"70","author":"Del Zar","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.lfs.2023.121906_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12438","article-title":"Melatonin suppresses platelet activation and function against cardiac ischemia\/reperfusion injury via PPAR\u03b3\/FUNDC1\/mitophagy pathways","volume":"63","author":"Zhou","year":"2017","journal-title":"J. Pineal Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.121906_bb0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-079X.1992.tb00055.x","article-title":"Binding sites for [3H]-melatonin in human platelets","volume":"13","author":"Vacas","year":"1992","journal-title":"J. Pineal Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.121906_bb0135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1600-079x.2002.1822.x","article-title":"2[125I]Iodomelatonin binding sites in guinea pig platelets","volume":"32","author":"Yau","year":"2002","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2023.121906_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114276","article-title":"The sodium-glucose cotransporter-2 (SGLT2) inhibitors synergize with nitric oxide and prostacyclin to reduce human platelet activation","volume":"182","author":"Lescano","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121906_bb0145","first-page":"10741","article-title":"Agomelatine modulates calcium signaling through protein kinase C and phospholipase C-mediated mechanisms in rat sensory neurons","volume":"234","author":"Serhatlioglu","year":"2019"},{"key":"10.1016\/j.lfs.2023.121906_bb0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bcp.2018.03.028","article-title":"Activation of soluble guanylyl cyclase with inhibition of multidrug resistance protein inhibitor-4 (MRP4) as a new antiplatelet therapy","volume":"152","author":"Mendes-Silverio","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121906_bb0155","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1476-5381.1996.tb16057.x","article-title":"Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation","volume":"119","author":"Donato","year":"1996","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.lfs.2023.121906_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047223","article-title":"Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway","volume":"7","author":"Mendes-Silverio","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.lfs.2023.121906_bb0165","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/0269881119827959","article-title":"Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics","volume":"33","author":"Saiz-Rodr\u00edguez","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121906_bb0170","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.bjp.0702658","article-title":"Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists","volume":"127","author":"Nonno","year":"1999","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.lfs.2023.121906_bb0175","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/cmdc.200900240","article-title":"N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands","volume":"4","author":"Rivara","year":"2009","journal-title":"ChemMedChem"},{"issue":"11","key":"10.1016\/j.lfs.2023.121906_bb0180","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/cmdc.201200303","article-title":"MT1-selective melatonin receptor ligands: synthesis, pharmacological evaluation, and molecular dynamics investigation of N-{[(3-O-substituted)anilino]alkyl}amides","volume":"7","author":"Rivara","year":"2012","journal-title":"ChemMedChem"},{"issue":"29","key":"10.1016\/j.lfs.2023.121906_bb0185","doi-asserted-by":"crossref","first-page":"19232","DOI":"10.1016\/S0021-9258(18)54987-5","article-title":"Different calcium pools in human platelets and their role in thromboxane A2 formation","volume":"266","author":"Br\u00fcne","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"1 Pt 2","key":"10.1016\/j.lfs.2023.121906_bb0190","first-page":"H1","article-title":"Thromboxane A2\/prostaglandin H2 mobilizes calcium in human blood platelets","volume":"249","author":"Brace","year":"1985","journal-title":"Am. J. Phys."},{"issue":"10","key":"10.1016\/j.lfs.2023.121906_bb0195","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1357-2725(98)00080-6","article-title":"Phospholipase A2: its role in ADP- and thrombin-induced platelet activation mechanisms","volume":"30","author":"Puri","year":"1998","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121906_bb0200","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/bph.14196","article-title":"Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond)","volume":"176","author":"Crescente","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121906_bb0205","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1600-079x.2002.1844.x","article-title":"Modulation of intracellular calcium and calmodulin by melatonin in MCF-7 human breast cancer cells","volume":"32","author":"Dai","year":"2002","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.lfs.2023.121906_bb0210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-079X.2007.00523.x","article-title":"Function and expression of melatonin receptors on human pancreatic islets","volume":"44","author":"Ramracheya","year":"2008","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.lfs.2023.121906_bb0215","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1600-079X.2005.00253.x","article-title":"Melatonin stimulates inositol-1,4,5-trisphosphate and Ca2+ release from INS1 insulinoma cells","volume":"39","author":"Bach","year":"2005","journal-title":"J. Pineal Res."},{"issue":"6","key":"10.1016\/j.lfs.2023.121906_bb0220","doi-asserted-by":"crossref","first-page":"L991","DOI":"10.1152\/ajplung.00273.2021","article-title":"Melatonin MT2 receptor is expressed and potentiates contraction in human airway smooth muscle","volume":"321","author":"Sasaki","year":"2021","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"14","key":"10.1016\/j.lfs.2023.121906_bb0225","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.febslet.2011.05.067","article-title":"Melatonin elevates intracellular free calcium in human platelets by inositol 1,4,5-trisphosphate independent mechanism","volume":"585","author":"Kumari","year":"2011","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.lfs.2023.121906_bb0230","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbrc.2013.07.053","article-title":"Melatonin elevates apoptosis in human platelets via ROS mediated mitochondrial damage","volume":"438","author":"Girish","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"18","key":"10.1016\/j.lfs.2023.121906_bb0235","doi-asserted-by":"crossref","first-page":"11537","DOI":"10.1074\/jbc.M114.559542","article-title":"Convergence of melatonin and serotonin (5-HT) signaling at MT2\/5-HT2C receptor heteromers","volume":"290","author":"Kamal","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2023.121906_bb0240","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202000305R","article-title":"Pharmacological evidence for transactivation within melatonin MT2 and serotonin 5-HT2C receptor heteromers in mouse brain","volume":"35","author":"Gerbier","year":"2021","journal-title":"FASEB J."},{"issue":"16","key":"10.1016\/j.lfs.2023.121906_bb0245","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1111\/bph.13950","article-title":"Melatonin receptors: molecular pharmacology and signalling in the context of system bias","volume":"175","author":"Cecon","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121906_bb0250","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1182\/blood-2004-05-2005","article-title":"The relative role of PLCbeta and PI3Kgamma in platelet activation","volume":"106","author":"Lian","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.lfs.2023.121906_bb0255","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood.V77.8.1734.1734","article-title":"Inhibition of platelet functions by a monoclonal antibody (LYP20) directed against a granule membrane glycoprotein (GMP-140\/PADGEM)","volume":"77","author":"Parmentier","year":"1991","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.lfs.2023.121906_bb0260","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/01.CIR.102.17.2045","article-title":"A new role for P-selectin in shear-induced platelet aggregation","volume":"102","author":"Merten","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.lfs.2023.121906_bb0265","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.bjp.0706734","article-title":"Recombinant P-selectin glycoprotein-ligand-1 delays thrombin-induced platelet aggregation: a new role for P-selectin in early aggregation","volume":"148","author":"Th\u00e9or\u00eat","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"16","key":"10.1016\/j.lfs.2023.121906_bb0270","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1161\/01.CIR.102.16.1931","article-title":"P-selectin expression on platelets determines size and stability of platelet aggregates","volume":"102","author":"Merten","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lfs.2023.121906_bb0275","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/01.ATV.0000149675.83552.83","article-title":"Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation","volume":"25","author":"Merten","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121906_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8081266","article-title":"Peptide antagonists for P-selectin discriminate between sulfatide-dependent platelet aggregation and PSGL-1-mediated cell adhesion","volume":"8","author":"Korporaal","year":"2019","journal-title":"J. Clin. Med."},{"issue":"Pt 3","key":"10.1016\/j.lfs.2023.121906_bb0285","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/bj2890641","article-title":"Eicosanoid\/thromboxane A2-independent and -dependent generation of lysoplasmenylethanolamine via phospholipase A2 in collagen-stimulated human platelets","volume":"289","author":"Turini","year":"1993","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.lfs.2023.121906_bb0290","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1124\/jpet.113.205591","article-title":"The effects of an inhibitor of diglyceride lipase on collagen-induced platelet activation","volume":"347","author":"Jackson","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.lfs.2023.121906_bb0295","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.thromres.2010.09.017","article-title":"A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation","volume":"126","author":"Tseng","year":"2010","journal-title":"Thromb. Res."},{"issue":"11","key":"10.1016\/j.lfs.2023.121906_bb0300","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/cvr\/27.11.1916","article-title":"Collagen induced human platelet aggregation: serotonin receptor antagonism retards aggregate growth in vitro","volume":"27","author":"Menys","year":"1993","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2023.121906_bb0305","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2017.02.028","article-title":"Serotonin-2A homodimers are needed for signalling via both phospholipase A2 and phospholipase C in transfected CHO cells","volume":"800","author":"Iglesias","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121906_bb0310","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00213-005-2231-5","article-title":"5-HT2A\/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter","volume":"180","author":"Qu","year":"2005","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.lfs.2023.121906_bb0315","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0026-895X(25)09405-2","article-title":"5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism","volume":"50","author":"Berg","year":"1996","journal-title":"Mol. Pharmacol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523005416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523005416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:44:01Z","timestamp":1744184641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523005416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":63,"alternative-id":["S0024320523005416"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121906","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agomelatine inhibits platelet aggregation through melatonin receptor-dependent and independent mechanisms","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"121906"}}